Quality‐adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90‐03: Phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma
Authors:
- 23 December 2008
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 31 (2) , 207-212
Abstract
Background.: To evaluate quality‐adjusted survival (QAS) of patients with locally advanced squamous cell carcinoma of the head and neck treated with 4 different radiation fractionation schedules.Methods.: QAS was calculated using the quality‐adjusted time without toxicity or relapse (Q‐TWiST) methodology. Utilities (patient preferences for certain health states) were obtained by threshold analysis. Q‐TWiST therefore equaled TWiST + ([weight for toxicity] × [time spent in toxicity]) + ([weight for relapse] × [time spent in relapse]).Results.: A statistically significant increase in QAS existed for patients treated with hyperfractionated radiotherapy compared with standard fractionated radiotherapy (SFX) with a toxicity utility ≥0.57 and relapse utility ≤0.72. No statistically significant difference was observed for patients treated with the other 2 fractionation schedules compared with SFX.Conclusion.: Q‐TWiST analysis identified patient groups that would benefit from more aggressive therapy. Further investigation with patient‐generated utilities is needed. © 2008 Wiley Periodicals, Inc. Head Neck, 2009Keywords
This publication has 15 references indexed in Scilit:
- Treatment, patient and tumor characteristics impact quality of life (QOL) in patients with locally advanced head and neck cancer: Report of the radiation therapy oncology group (RTOG) trial 90-03International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Age and marital status linked to quality of life of long term survivors of head and neck or prostate cancer: report from a survey of radiation therapy oncology group patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Quality of Life After Treatment for Advanced Laryngeal and Hypopharyngeal CancerThe Laryngoscope, 2001
- Quality of life in laryngectomees: a post-treatment comparison of laryngectomy alone versus combined therapyThe Journal of Laryngology & Otology, 2001
- Neurocognitive outcome in brain metastasis patients treated with accelerated fractionation (AF) vs. accelerated hyperfractionation (AH) whole brain radiotherapy (WBRT): An analysis from radiation therapy oncology group (RTOG) study 91-04International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Quality of Life in Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2000
- Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Comparing Treatments Using Quality-Adjusted Survival: The Q-Twist MethodThe American Statistician, 1995
- Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Quality adjusted survival analysisStatistics in Medicine, 1990